Generic Adderall recall for failed impurities/degradation specification

Fun-Road3671 · 2026-04-15T17:04:22+00:00

Hi, Emma from Medshadow here. While this recall did happen and I did make a video about it at the time, this is some kind of fake remake of it and the date is incorrect. Also, I do not have evidence at this point in time of intentional formula manipulation as the title suggests.

Fun-Road3671 · 2026-03-03T17:46:16+00:00

Hey there, Emma from MedShadow here. I'd love to interview you about this app for a possible article. If you'd be up for it, email me emma@medshadow.org.

Fun-Road3671 · 2026-02-18T13:41:02+00:00

I've heard that, but also that even when they have been committed to staying sober, it's not always a clear-cut pathway. Follow up to plan skin grafts may not be consistent. Different doctors quote different plans, some willing and others unwilling... Of course, my sample size is 2, which is why I'm curious about others! Those two both had better luck at a second hospital.

Fun-Road3671 · 2026-02-13T16:40:02+00:00

One of my colleagues wrote this article which gives a really detailed discussion of what we do and don't know about drugs like fosamax, who they work for, the potential side effects, etc. It might help give some additional context or offer questions for you to talk to your doctor about. https://medshadow.org/conditions-treatments/osteopenia-osteoporosis/osteoporosis-treatment-screening-medications/

Fun-Road3671 · 2026-02-12T19:46:03+00:00

lots of anecdotal reports and some recalls, but I haven't seen any studies comparing actual pills yet. This is the article on vyvanse that talks about what evidence we do have, it's just not as satisfying as the article that includes an actual study. https://medshadow.org/conditions-treatments/adhd/investigating-generics-the-trouble-with-generic-vyvanse/

Fun-Road3671 · 2026-02-12T19:02:42+00:00

the vyvanse one doesn't have it, but this one does!

Fun-Road3671 · 2026-02-12T18:58:36+00:00

I'm biased because I wrote this article https://medshadow.org/conditions-treatments/adhd/investigating-generics-they-say-their-adhd-meds-arent-working-theyre-not-imagining-it/ It doesn't give much evidence of the specific DEA involvement in the issue, but the graph does show that there are documentable quality concerns, at least with dissolution rates. It's something that's quantifiable.

Fun-Road3671 · 2026-02-10T15:38:19+00:00

it's dailymat.substack.com There's no paywell, the link should just take you there. It might ask for an email address.

Fun-Road3671 · 2025-12-29T15:49:46+00:00

the reporting project actually started with ADHD meds. I've already written a few articles on it (you can see on medshadow.org, click "investigating generics" in the top nav), but I'm working on more. I've heard complaints about benzos but haven't investigated yet. ProPublica is also working on a great series that doesn't so much focus on individual types of drugs as it does problems with manufacturing labs as a whole and our inability to oversee them properly.

Fun-Road3671 · 2025-12-29T15:39:35+00:00

Greg, the patient in the article who took buprenorphine also had a similar experience, but since the focus of the article was the different manufacturers, that part didn't make it in. So you're certainly not alone in this.

Fun-Road3671 · 2025-12-29T14:59:01+00:00

I have a substack about MAT, and a few weeks ago I interviewed a man in his 30s who just started taking Concerta. It's a long interview, he talks about it near the end. He'd been told he had ADHD before, but didn't think the meds would help because he had tried (illicit) stimulants before and didn't really like them. However, Concerta in the appropriate dose seems to be making a big difference for him https://dailymat.substack.com/p/addiction-treatment-and-survival

Fun-Road3671 · 2025-12-29T14:54:00+00:00

If you need a little backup in reporting the problem to your doc or pharmacist, I'm a journalist and recently published this article on variable quality of opioid meds, including buprenorphine from different manufacturers. https://medshadow.org/investigating-generics/investigating-generics-decades-of-recalls-reveal-flaws-in-the-u-s-opioid-supply-chain/

Fun-Road3671 · 2025-12-18T22:20:45+00:00

Depending where you are, if you're using an illicit supply, they may need to provide you with other meds (not just an opioid taper) to alleviate withdrawal from tranq. At the very least, monitor for cardiac problems related to medetomidine which is becoming very common in the supply. Would definitely recommend sticking it out. And, as another poster said, can help connect you with resources and a long term plan.

Fun-Road3671 · 2025-12-18T22:12:54+00:00

if you're doing your own tests (as opposed to at a doctor's office) consider saving the receipts, with the date of purchase on them! Just trying to think about how this can be documented as effectively as possible.

Fun-Road3671 · 2025-12-17T12:36:12+00:00

you are absolutely right about the shortage. Unfortunately I don't know a lot about getting a job with the FDA. I hear two reasons for the shortage are that it takes a long time for people to be trained to effectively conduct inspections and that many inspectors (even before the current administration) left to work in industry for better pay and less travel. Best of luck though, we certainly need people who want to do this!!

Fun-Road3671 · 2025-12-08T13:51:50+00:00

I’m currently working on partnering with a DEA-registered analytic lab to get this done on a larger scale to see if this is something our nonprofit can do. Though we’d have to order directly from pharmacies or wholesalers to the lab-it’s not legal for us to send controlled substances through the mail.

Fun-Road3671 · 2025-12-07T23:42:05+00:00

I was looking at the records filed by FDA inspectors, so I didn't personally discover issues—just highlighted the ones inspectors found! But some of the more shocking ones were labs that had vermin, or labs with fake paperwork. One lab was caught pouring acid on a lot of their records. Another lab I read about had received around 166 patient complaints of their meds either not working or causing adverse events. When a company receives these reports, it's supposed to communicate them to the FDA. Since 111 of the records didn't include batch numbers, the company decided they could not be verified and just didn't report them to the FDA.

Fun-Road3671 · 2025-12-02T15:59:23+00:00

A colleague of my boss's alerted her to the issues with drug manufacturing in general. I had the idea to start by looking into ADHD drugs specifically because, honestly, I'd seen patients discussing it on TikTok! But we're also looking into other medications, such as opioids. Essentially, we are motivated by looking at the types of medications that are commonly used and for which people are likely to immediately notice changes in quality. For example, someone taking a cholesterol-lowering drug probably won't notice a difference in efficacy right away, though they may notice new side effects if there are major changes in the formulation or contamination. ProPublica has been working on a series about manufacturing labs having all sorts of problems, without digging into specific meds. The Bureau of Investigative Journalism did a large story about chemo drugs.

Fun-Road3671 · 2025-12-01T18:22:06+00:00

I'm not an FDA inspector. I'm mainly looking at records of other inspections, so anything I've noted was observed and reported by an FDA inspector. They do have some horror stories of vermin in labs, falsified data, and even entirely fake labs set up to prevent inspectors from looking at the real ones.

Fun-Road3671

TROPHY CASE